Hans Lennart Rudolf Wigzell, Director at Sarepta Therapeutics, Inc. (SRPT), sold 7,900 shares at $151.22 ($1.2M) on 2020-05-20, disclosed to the SEC on 2020-05-22.
Open-market sale of $1.2M SRPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $149.62 | 2,100 | $314K | 26.4% |
| 2 | $151.22 | 2,046 | $309K | 26.0% |
| 3 | $151.22 | 2,046 | $309K | 26.0% |
| 4 | $151.77 | 854 | $130K | 10.9% |
| 5 | $151.77 | 854 | $130K | 10.9% |
| Total | $150.91 avg | 7,900 |
| $1.2M |
| 100% |
| Filing → |
| SRPT | SELL | 2023-08-08 | $1.6M | — | Filing → |
| SRPT | SELL | 2021-03-10 | $835K | — | Filing → |
| SRPT | SELL | 2020-08-11 | $3.2M | — | Filing → |